Bharat Immunologicals & Biologicals Corporation Q3 Results

  • BSE: 524663
  • NSE: -
  • ISIN: INE994B01014
  • Sector: Major Drugs
BSE
23.630.01 (0.04%)
Volume31.58 K
Updated: Mon 25 Nov, 2024 | 15:49:10
NSE
This stock is not traded on NSE
Today: 23.26
24.20
52-Wk: 22.25
43.89

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Bharat Immunologicals & Biologicals Corporation Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 22Sep 22QoQ Comp
    Total Revenue 0.0026.48-%
    Depreciation/ Amortization 0.040.04-%
    Other Operating Expenses Total 1.950.65-%
    Total Operating Expense 4.7629.02-%
    Operating Income -4.76-2.54-%
    Net Income Before Taxes -6.33-3.96-%
    Net Income -4.68-3.08-%
    Diluted Normalized EPS -1.08-0.71-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts